Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-08-13 |
2024-06 |
0 |
-1.64 |
N/A |
N/A |
2024-05-13 |
2024-03 |
0 |
-3.71 |
N/A |
N/A |
2024-03-28 |
2023-12 |
0 |
0.33 |
N/A |
N/A |
2023-11-13 |
2023-09 |
0 |
0.29 |
N/A |
N/A |
2023-08-14 |
2023-06 |
0 |
-0.93 |
N/A |
N/A |
2023-05-15 |
2023-03 |
0 |
0.42 |
N/A |
N/A |
Date |
Name |
Relation |
Quantity |
Description |
2019-10-29 |
EVANS DAVID W |
Officer and Director |
1.54M |
Stock Award(Grant) |
2019-04-08 |
FAVISH MICHAEL |
Chief Executive Officer |
3.25M |
Stock Award(Grant) |
2021-08-29 |
GAGLIANO DONALD A |
Director |
27.75K |
Purchase |
2019-04-07 |
GOLDSTONE MARK |
Director |
525.30K |
Stock Award(Grant) |
2024-08-25 |
RADOFF BRADLEY LOUIS |
Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Sale |
2021-08-30 |
SCHOLTES BRET D |
Chief Executive Officer |
179.48K |
Purchase |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Renaissance Technologies, LLC |
37.62K |
292.68K |
2.95% |
2023-06-29 |
Blackrock Inc. |
10.03K |
78.03K |
0.79% |
2023-06-29 |
Barclays Plc |
900.00 |
7.00K |
0.07% |
2023-06-29 |
Morgan Stanley |
659.00 |
5.13K |
0.05% |
2023-06-29 |
Citigroup Inc. |
373.00 |
2.90K |
0.03% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Extended Market Index Fund |
3.17K |
24.62K |
0.25% |
2023-05-30 |
Fidelity Extended Market Index Fund |
1.94K |
11.96K |
0.15% |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
527.00 |
3.25K |
0.04% |
2023-05-30 |
Fidelity Series Total Market Index Fund |
375.00 |
2.31K |
0.03% |
2023-05-30 |
Fidelity Total Market Index Fund |
430.00 |
2.65K |
0.03% |
Dividend |
Date |
5 |
2024-09-24 |
5 |
2024-09-09 |
Split |
Date |
1 : 50 |
2023-01-09 |
1 : 6 |
2021-03-01 |